RxDoctor Payments Data

Stuart Hough, MD

Interventional Pain Medicine · Rockville, MDNPI 1568417871

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,888 of the $3,104 with a category attached, or 60.8%. 12 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 36.1% of the total. 2025 is the largest year on record at $1,356, 8.0 times the $169 reported in 2019. That places this record below the midpoint for interventional pain medicine clinicians in MD, where the typical reported total is $3,506.

$3,104in general payments, 2019–2025

Across 49 payments — averaging $63.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pacira Pharmaceuticals Incorporated$1K
  • Relievant Medsystems, Inc.$540
  • Nevro Corp.$329
  • Saluda Medical Americas, Inc.$328
  • Vertos Medical, Inc.$228
  • Medtronic$210
  • plus $350 from 6 others

What the payments were for

  • Travel & lodging$1,21639%
  • Food & beverage$1,88861%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,104 in reported general payments places this provider in the 45th percentile of 56 interventional pain medicine providers in Maryland.

See all interventional pain medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$296,431
Medicare patients
638
Services billed
10,926

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl58$1,228
Pregabalin36$1,005
Oxycodone Hcl51$871
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen41$797
Gabapentin53$695
Hydromorphone Hcl26$421
Tizanidine Hcl20$358
Cyclobenzaprine Hcl26$333
Amitriptyline Hcl13$263
Tramadol Hcl59$175
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$166
Ibuprofen13$20

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Rockville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →